Korea Quality Re-Rating Watch 2026-11-10: Dongkuk Pharma, Nano New Material — Bear Bounce Surfaces Re-Pricers

KOSPI bear regime persists at 5,239. Nov 10 broad bounce (+2.57% avg) surfaces Dongkuk Pharma leading a rare 4-family meta screener signal.

— Recommendations 0

Macro Dashboard

IndicatorLevel5-Day ChangeSignal
KOSPI5,239−7.8%Bear
KOSDAQ668−6.6%Bear
USD/KRW1,339−0.3%Flat
VIX20.2+21.4%Caution
US 10Y4.86%−9 bpsFlat
Brent$91.1−7.3%Weak
DXY101.7Flat—

KR regime: Bear | US regime: Neutral (as of 2026-11-10 20:20 KST; 11/12 inputs current)

Both KOSPI and KOSDAQ remain well below their 200-day moving averages. Only 17.7% of 2,692 tracked Korean stocks trade above their 50-day average — bear breadth by any measure. The US regime slipped from Bull to Neutral after VIX crossed 20 (20.17 current), capping the index-based Bull read. Korean breadth at 17.7% vs. US at 39.0% marks a substantial divergence. Brent’s -7.3% five-day slide and a negative futures basis (−2.21) add macro headwinds for Korea’s energy-linked names.


Market Wrap

Source: KR Market Snapshot (2026-11-10 DB). Full close briefing not available; trading summary derived from same-day DB.

Today’s session delivered a sharp breadth reversal inside a confirmed bear regime. Of 2,593 tracked names, 1,906 advanced against 462 decliners (ADR proxy 412.6), with the average stock gaining +2.57%. The regime data reflects cumulative five-day damage — KOSPI −7.8%, KOSDAQ −6.6% — but today itself was Day 1 of a rally attempt. The character: broad, sector-led, with meaningful double-sided institutional commitment in select names.

Airlines and travel led the session decisively. Korean Air (003490.KS, +11.51%) attracted both foreign and institutional net buying, a rare simultaneous inflow that signals conviction rather than a short-covering flush. Hanjin KAL (180640.KS) surged +15.18% and Daewoo E&C (047040.KS) added +9.21% with foreign support. The move reads as capacity-recovery positioning; Jeju Air (089590.KQ) and Jin Air (272450.KQ) are screened candidates in the same theme (see Section 3).

Battery and secondary-cell names saw coordinated buying. Samsung SDI (006400.KS, +9.88%) drew foreign and institutional inflows simultaneously — the kind of double conviction that tends to mark a durable floor attempt. Eco Pro (086520.KS, +10.23%) and Eco Pro BM (247540.KS, +8.70%) were institutional-led. LG Energy Solution (373220.KS, +3.93%) attracted institutional buying despite foreign selling, suggesting domestic funds used the dip to reload. The common thread: battery raw material and cell names moving together on institutional direction.

Industrials and special situations added breadth. HD Construction Machinery (267270.KS, +12.30%) was institutional-bought. SFA Semiconductor (036540.KS, +13.17%) and Exicon (092870.KS, +13.14%) surged but on foreign selling — a retail/institutional divergence worth watching.

Weak spots were concentrated: KT&G (033780.KS, −3.67%) saw both foreign and institutional selling, standing out as the clearest risk-off name on a broadly green tape. Samsung Biologics (207940.KS, −2.78%) and KT (030200.KS, −2.30%) also faced institutional outflows. The pattern — quality defensives and telecom underperforming on a bounce day — suggests the rotation was pro-cyclical and sentiment-driven rather than a defensive rotation.

The bear regime label reflects cumulative breadth damage; today’s session does not invalidate it. The next confirmation of a rally attempt requires a follow-through day on higher volume in the coming sessions.


Today’s Quality Re-Rating Candidates

Today’s meta screener processed 103 tickers, scoring by weighted multi-family signal overlap. The empirical weights place earnings estimate revision (2.22×) and RS80 price leadership (1.34×) above the financial-factor cluster (0.56×). No pure two-screener PEAD intersection emerged in isolation, but the meta screener’s multi-family detection surfaces one clear leader and several credible second-tier candidates.

RankTickerNameFamiliesScoreScreeners HitKey Metrics
1086450.KSDongkuk Pharmaceutical481.3Quality Compounder, Cycle Rerating, PEAD, Quiet AccumulationROE 9.9%, OP YoY +20%, Δmargin +0.5pp
2121600.KQNano New Material232.3Cycle Rerating, Consensus UpΔmargin +0.8pp, consensus z +0.65
3002790.KSAmorepacific Holdings230.4Quiet Accumulation, RS80Pivot gap +4.3%, box risk −17.0%
4002900.KSTYM224.4Consensus Up, PEADOP YoY +298%, consensus z +0.72
5089590.KQJeju Air123.3Consensus UpConsensus z +5.57, IR event filed
6003670.KSPOSCO Future M122.6Consensus UpConsensus z +0.95, preliminary earnings filed
7272450.KQJin Air121.9Consensus UpConsensus z +0.63, two IR events filed
8293490.KQKakao Games120.0Consensus UpConsensus z +0.55, earnings + IR catalyst

Dongkuk Pharmaceutical (086450.KS) — four-family leader

Dongkuk Pharma is a mid-cap Korean specialty pharmaceutical and consumer health company. It is the only name today passing four independent screener families: Quality Compounder, Cycle Rerating, PEAD, and Quiet Accumulation — producing a composite score of 81.3, nearly 2.5× its nearest rival. ROE stands at 9.9%, operating profit grew +20% YoY with margin expansion of +0.5pp, and the stock sits +10.2% below its 52-week high with a positive MA50 confirmation. Retail outflows of −5.75bn won are being absorbed by foreign and quality-institutional buyers. The DART filing lookback shows no risk filings in the 21-day window. The key check: determine whether the YoY operating leverage reflects a structural cost shift or a base-effect quarter. The post-earnings drift window remains open.

Nano New Material (121600.KQ) — cycle plus consensus

This KOSDAQ-listed advanced materials company — a supplier of CMP slurry and functional film to semiconductor fabs — hits both Cycle Rerating and Consensus Up. Operating margin expanded +0.8pp; consensus composite z-score is +0.65. Foreign and institutional buyers are absorbing −10.39bn won in retail supply. A Nov 6 DART filing for treasury share disposal adds a corporate action catalyst. The re-rating logic is straightforward: semiconductor fab utilization recovery feeds consumables demand, and analysts are beginning to price it in. Liquidity is thin; position sizing requires a volume check before entry.

Amorepacific Holdings (002790.KS) — quiet accumulation plus price leadership

Korea’s largest cosmetics holding company passes Quiet Accumulation (foreign ownership rising in a narrow price range) and RS80 Not-Late Leadership (Focus Candidate tier, pivot gap +4.3%, box risk −17.0%). A self-tender buyback completion filed with DART on Nov 2 is the official corporate catalyst. The re-rating question hinges on China consumer recovery: does the next quarterly earnings print show volume inflection in the Greater China segment? Consensus was revised upward four times in the DART lookback window. Worth monitoring for the earnings follow-through.


Screener data: KR Meta Screener 2026-11-10. Market snapshot: same-day DB. Macro regime: 11/12 inputs current as of 20:20 KST. Candidates flagged for further research; not investment recommendations.

Built with Hugo
Theme Stack designed by Jimmy